SCM Lifescience Co., Ltd. (KOSDAQ: 298060)
South Korea
· Delayed Price · Currency is KRW
2,175.00
-70.00 (-3.12%)
Oct 11, 2024, 9:00 AM KST
SCM Lifescience Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Oct '24 Oct 10, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 43,391 | 77,366 | 175,143 | 233,826 | 586,015 | - | |
| Market Cap Growth | -29.42% | -55.83% | -25.10% | -60.10% | - | - | |
| Enterprise Value | 40,957 | 65,415 | 170,464 | 217,178 | 551,155 | - | |
| Last Close Price | 2120.00 | 3780.00 | 10694.08 | 14394.46 | 36522.70 | - | |
| PE Ratio | - | -2.58 | -6.76 | -7.65 | -40.22 | - | |
| PS Ratio | 43.32 | 111.21 | 442.30 | 532.31 | 1831.26 | - | |
| PB Ratio | 2.90 | 3.78 | 7.15 | 5.24 | 9.29 | - | |
| P/FCF Ratio | -4.87 | -6.25 | -14.98 | -16.61 | -47.38 | - | |
| P/OCF Ratio | -4.96 | -6.37 | -15.66 | -17.44 | -53.81 | - | |
| EV/Sales Ratio | 40.81 | 94.03 | 430.48 | 494.41 | 1722.33 | - | |
| EV/EBITDA Ratio | -4.33 | -5.38 | -14.77 | -19.71 | -37.10 | - | |
| EV/EBIT Ratio | -4.06 | -5.03 | -13.55 | -17.87 | -34.26 | - | |
| EV/FCF Ratio | -3.61 | -5.29 | -14.58 | -15.42 | -44.56 | - | |
| Debt / Equity Ratio | 0.27 | 0.19 | 0.24 | 0.14 | 0.11 | 0.18 | |
| Debt / FCF Ratio | -0.36 | -0.31 | -0.49 | -0.44 | -0.54 | -0.23 | |
| Asset Turnover | 0.05 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 | |
| Inventory Turnover | 1.60 | 1.53 | 1.29 | 0.85 | 0.55 | 0.43 | |
| Quick Ratio | 5.74 | 10.85 | 1.97 | 2.27 | 10.85 | 2.24 | |
| Current Ratio | 6.37 | 11.55 | 2.20 | 2.33 | 11.07 | 2.30 | |
| Return on Equity (ROE) | -124.29% | -106.53% | -66.34% | -41.82% | -22.27% | - | |
| Return on Assets (ROA) | -35.81% | -27.81% | -18.06% | -11.66% | -17.14% | -17.97% | |
| Return on Capital (ROIC) | -38.14% | -29.77% | -19.40% | -12.61% | -20.68% | -74.18% | |
| Earnings Yield | -43.12% | -30.97% | -13.09% | -9.63% | -1.64% | - | |
| FCF Yield | -26.18% | -15.99% | -6.67% | -6.02% | -2.11% | - | |
| Buyback Yield / Dilution | -40.76% | -12.84% | -21.21% | -12.79% | -101.51% | -58.63% | |
| Total Shareholder Return | -40.76% | -12.84% | -21.21% | -12.79% | -101.51% | -58.63% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.